MIRA INFORM REPORT
|
Report Date : |
17.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
KARL STORZ GMBH & CO KG |
|
|
|
|
Registered Office : |
Mittelstrasse 8, Tuttlingen, 78532 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Year of Establishment : |
1945 |
|
|
|
|
Com. Reg. No.: |
450442 |
|
|
|
|
Legal Form : |
Partnership Parent Company |
|
|
|
|
Line of Business : |
Development,
manufacture and sale of medical instruments, particularly endoscopic
equipment |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Germany |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
Karl Storz GmbH & Co KG
Mittelstrasse 8
Tuttlingen, 78532
Germany
Tel: 49 (7461) 7 08-0
Fax: 49 (7461) 7 08-105
Web: www.karlstorz.de
synthesis
Employees: 3,800
Company Type: Partnership Parent
Corporate Family: 16
Companies
Incorporation Date: 1945
Financials in: USD
(Millions)
Fiscal Year End:
31-Dec-2009
Reporting Currency: Euro
Annual Sales: 1,204.7
Total Assets: 828.8
Business Description
Karl Storz GmbH
& Co. KG is primarily engaged in manufacture of instruments and appliances
used for medical, surgical, dental or veterinary purposes (electro-diagnostic
apparatus such as electrocardiographs, ultrasonic diagnostic equipment,
scintillation scanners, nuclear magnetic resonance apparatus, dental drill
engines, sterilizers, ophthalmic instruments); manufacture of syringes, needles
used in medicine, mirrors, reflectors, endoscopes, etc.; manufacture of
apparatus based on the use of X-rays or alpha, beta or gamma radiation whether
ornot for use in human or animal medicine (X-ray tubes, high tension
generators, control panels, desks, screens, etc.); manufacture of medical,
surgical, dental or veterinary furniture (operating tables, hospital beds with
mechanical fittings, dentists’ chairs); and manufacture of mechano-therapy
appliances, massage apparatus, psychological testing apparatus, ozone therapy,
oxygen therapy, artificial respiration apparatus, gas masks, etc. This class
also includes: manufacture of orthopaedic appliances (crutches, surgical belts
and trusses, splints, artificial teeth, artificial limbs and other artificial
parts of the body, hearing aids, pace-makers, orthopaedic shoes, etc.).
Industry
Industry Medical Equipment and Supplies
ANZSIC 2006: 2412 - Medical and
Surgical Equipment Manufacturing
NACE 2002: 3310 - Manufacture
of medical and surgical equipment and orthopaedic appliances
NAICS 2002: 334510 -
Electromedical and Electrotherapeutic Apparatus Manufacturing
UK SIC 2003: 3310 - Manufacture
of medical and surgical equipment and orthopaedic appliances
US SIC 1987: 3845 -
Electromedical and Electrotherapeutic Apparatus
Key Executives
Name Title
Sybill Storz Geschaftsfuhrerin
Karl-Christian Storz Geschaftsfuhrer
Stefan Ahlhaus Leiter-Personal
News
|
Title |
Date |
|
USPTO
ISSUES TRADEMARK: DBLADE |
15-Oct-2011 |
|
US Patent
Issued to KARL STORZ GmbH & Co. KG on May 31 for "Medical
Device" (British Inventor) |
1-Jun-2011 |
|
US Patent
Issued to Karl Storz on May 24 for "Mobile Endoscopic Documentation
System" (German Inventors) |
29-May-2011 |
|
US Patent
Issued to Karl Storz on May 24 for "Guiding Instrument" (German
Inventors) |
28-May-2011 |
|
US Patent
Issued to Karl Storz on May 24 for "Optical Cube" (German Inventor) |
28-May-2011 |
Registered No.(DEU): 450442
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7190468
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.6969855
Corporate Overview
Location
Mittelstrasse 8
Tuttlingen, 78532
Germany
Tel: 49 (7461) 7 08-0
Fax: 49 (7461) 7 08-105
Web: www.karlstorz.de
Sales EUR(mil): 866.3
Assets EUR(mil): 577.7
Employees: 3,800
Fiscal Year End: 31-Dec-2009
Industry: Medical Equipment and Supplies
Incorporation Date: 1945
Company Type: Partnership Parent
Quoted Status: Not Quoted
Registered No.(DEU): 450442
Geschaftsfuhrer Karl-Christian
Storz
Contents
· Industry Codes
· Business Description
· Financial Data
· Subsidiaries
· Key Corporate Relationships
Industry Codes
ANZSIC 2006 Codes:
2412 - Medical and Surgical Equipment Manufacturing
NACE 2002 Codes:
3310 - Manufacture of medical and surgical equipment and
orthopaedic appliances
NAICS 2002 Codes:
334510 - Electromedical and Electrotherapeutic Apparatus
Manufacturing
US SIC 1987:
3845 - Electromedical and Electrotherapeutic Apparatus
UK SIC 2003:
3310 - Manufacture of medical and surgical equipment and
orthopaedic appliances
Business
Description
Development,
manufacture and sale of medical instruments, particularly endoscopic equipment
More Business Descriptions
· Karl Storz GmbH & Co. KG is primarily engaged in manufacture of instruments and appliances used for medical, surgical, dental or veterinary purposes (electro-diagnostic apparatus such as electrocardiographs, ultrasonic diagnostic equipment, scintillation scanners, nuclear magnetic resonance apparatus, dental drill engines, sterilizers, ophthalmic instruments); manufacture of syringes, needles used in medicine, mirrors, reflectors, endoscopes, etc.; manufacture of apparatus based on the use of X-rays or alpha, beta or gamma radiation whether ornot for use in human or animal medicine (X-ray tubes, high tension generators, control panels, desks, screens, etc.); manufacture of medical, surgical, dental or veterinary furniture (operating tables, hospital beds with mechanical fittings, dentists’ chairs); and manufacture of mechano-therapy appliances, massage apparatus, psychological testing apparatus, ozone therapy, oxygen therapy, artificial respiration apparatus, gas masks, etc. This class also includes: manufacture of orthopaedic appliances (crutches, surgical belts and trusses, splints, artificial teeth, artificial limbs and other artificial parts of the body, hearing aids, pace-makers, orthopaedic shoes, etc.).
· Navigational, Measuring, Medical, and Control Instruments Manufacturing
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Strategic Initiatives
The Strategic Initiatives report is created using
technology to extract meaningful insights from analyst reports about a
company's strategic projects and investments. More about Strategic Initiatives
Partnerships
The company is in
the market for more than 50 years and has over 400 national and international
patents and prototypes, providing the company the much needed competitive edge
in the market. Karl Storz provides endoscopy systems in all areas of veterinary
medicine. These are developed in collaboration with veterinarians at
universities, private practices and research centers. It provides medicines
including numerous soft tissue and orthopedic applications for small animals.
The company also provides specialized products for large animals which include
laparoscopy, arthroscopy, teat endoscopy, etc., keeping in mind the current
need to extend to animals the refined diagnostic and surgical techniques
available to humans.
Source:
GlobalData, February 17, 2011
|
Corporate
Family |
Corporate
Structure News: |
|
|
|
|
Karl Storz GmbH & Co KG |
|
|
|
|
|
Company
Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
Tuttlingen |
Germany |
Medical Equipment and Supplies |
1,204.7 |
3,800 |
|
|
|
Subsidiary |
Tuttlingen, Baden-Württemberg |
Germany |
Biotechnology and Drugs |
|
1,500 |
|
|
|
Subsidiary |
Guyancourt |
France |
Personal and Household Products |
|
149 |
|
|
|
Subsidiary |
Dundee |
United Kingdom |
Medical Equipment and Supplies |
53.4 |
140 |
|
|
|
Subsidiary |
Nottingham |
United Kingdom |
Computer Hardware |
|
8 |
|
|
|
Subsidiary |
Nottingham |
United Kingdom |
Nonclassifiable Industries |
|
|
|
|
|
Subsidiary |
Tuttlingen, Baden-Württemberg |
Germany |
Medical Equipment and Supplies |
|
80 |
|
|
|
Subsidiary |
San Fernando De Henares, Madrid |
Spain |
Personal and Household Products |
28.7 |
70 |
|
|
|
Subsidiary |
Verona, Verona |
Italy |
Miscellaneous Capital Goods |
10.6 |
40 |
|
|
|
Subsidiary |
Elzach, Baden-Württemberg |
Germany |
Miscellaneous Fabricated Products |
|
30 |
|
|
|
Subsidiary |
Bad Krozingen, Baden-Württemberg |
Germany |
Medical Equipment and Supplies |
|
15 |
|
|
|
Subsidiary |
El Segundo, CA |
United States |
Medical Equipment and Supplies |
|
|
|
|
|
Branch |
Stafford, TX |
United States |
Medical Equipment and Supplies |
16.1 |
50 |
|
Executive report
|
Executives |
|
|
|
|
|||
|
Geschaftshrerin |
Chief Executive Officer |
|
|||
|
Geschäftsführer |
Chief Executive Officer |
|
|||
|
Leiter-Personal |
Human Resources Executive |
|
Press Clippings
US Patent Issued
to Karl Storz on May 24 for "Optical Cube" (German Inventor)
U.S. Fed News: 28
May 2011
[What follows is
the full text of the news story.]
ALEXANDRIA, Va.,
May 28 -- United States Patent no. D638,542, issued on May 24, was assigned to
Karl Storz GmbH & Co. KG (Germany).
"Optical
Cube" was invented by Peter Eisenkolb (Tuttlingen, Germany).
The patent was
filed on June 22, 2010, under Application No. D/364,306.
For any query with respect to this article or any other content
requirement, please contact Editor at htsyndication@hindustantimes.com
Karl Storz GmbH & Co. Develops Design Patent
(233438) for Endoscope with a Connector for Light and Image Transmission
Indian Patent News
06 October 2011
[What follows is the full text of the article.]
New Delhi, Oct. 6
-- Karl Storz GmbH & Co., Tuttlingen, Germany, has been developed a Design
patent (233438) for an endoscope with a connector for light and image
transmission.
The Design was registered on Dec. 21, 2010 under Class No. 24-02 titled
as "endoscope with a connector for light and image transmission."
About the Company
KARL STORZ has established itself worldwide as an international and
highly regarded company in the production and sale of medical instruments and
devices.
Indian Patent News
Related Topics
Legal
Related
Geographies
Asia
Germany
India
GERMANY : Karl
Storz GmbH & Co.KG wins the contract for endoscopy, endosurgery devices
TendersInfo News
04 March 2011
[What follows is
the full text of the article.]
Vivantes Netzwerk
fuer Gesundheit GmbH has awarded the contract to Karl Storz GmbH & Co.KG,
for endoscopy, endosurgery devices. Open procedure was followed for awarding
this contract. The contract is not covered by the Government Procurement
Agreement (GPA) and will not be sub-contracted to third party.
Scope of work is
to delivery, installation and handing over of 4 pieces of endoscopy systems for
the Central-op area of use of different equipment in the accident and
reconstructive surgery, gynecology / urology, and one endoscopy system
optional.
The contractor was
selected after scrutinizing 5 bidders who did bidding for this contract. The
contractor was not selected through an electronic auction process. The contracting
authority is purchasing on behalf of other contracting authorities.
TendersInfo News
Related Geographies
Germany
Karl Storz GmbH
& Co. KG Files Patent Application for Endoscopic Stitching Machine
Indian Patent News
28 January 2011
[What follows is the full text of the article.]
New Delhi, Jan. 28
-- Germany based Karl Storz GmbH & Co. KG filed patent application for
endoscopic stitching machine. The Inventors are Klundt Kurt and Moll Philipp.
Karl Storz GmbH
& Co. KG filed the patent application April 23, 2007. The patent
application number is 1437/KOLNP/2007 A. The International classification
number is H04L29/06.
According to the
Controller General of Patents, Designs & Trade Marks, "The invention
relates to an endoscopic stitching machine, comprising a housing for mounting
the actuators for the stitch-forming tools (needle, gripper and pressure pad),
and a housing shaft to house means for transmission of the movements generated
by the actuators to the stitch-forming tools, whereby the housing shaft and the
transmission means are divided into two shaft parts and lower and upper
transmission means, in a plane perpendicular to the longitudinal direction
thereof, detachably connected to each other by means of a corresponding
coupling piece, whereby the coupling pieces may be introduced into and
positively housed within corresponding recesses of the lower and upper
transmission means, parallel to the section plane and running in the
longitudinal direction of the transmission means."
Indian Patent News
Related Topics
Legal
GERMANY : Karl
Storz GmbH & Co. KG bags contract for medical equipments
TendersInfo News
25 November 2010
[What follows is
the full text of the article.]
Bundesamt fur
Wehrtechnik und Beschaffung,DE based company awarded contract to Karl Storz
GmbH & Co. KG for medical equipments. The final value of the contract is
not disclosed.
The main place of
delivery Berlin, Koblenz, Westerstede. Contract is issued for small fiber
optics. This contract is covered by the Government Procurement Agreement (GPA).
Contract has been
awarded by using Negotiated without a call for competition method and
electronic auction not has been used while issuing this contract. There was
only one bidder for bidding the contract.
There is no
intention that contract will be sub-contracted.
Annual Profit & Loss
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.719047 |
0.683679 |
0.730637 |
|
Consolidated |
Yes |
Yes |
Yes |
|
|
|
|
|
|
Total income |
1,204.7 |
1,298.8 |
1,075.4 |
|
Net sales |
1,204.7 |
1,298.8 |
1,075.4 |
|
Other operating income |
38.8 |
49.9 |
38.6 |
|
Cost of sales |
566.8 |
576.5 |
514.8 |
|
Gross profit |
638.0 |
722.4 |
560.6 |
|
Advertising, distribution, and commercial
expenses |
391.1 |
399.0 |
342.6 |
|
General expenses |
124.0 |
130.2 |
109.0 |
|
Other operating costs |
92.7 |
146.7 |
83.0 |
|
Net operating
income |
68.9 |
96.4 |
64.6 |
|
Interest received from loans |
0.0 |
0.2 |
0.1 |
|
Income received from associated companies |
0.2 |
0.2 |
0.1 |
|
Other income |
2.7 |
4.9 |
3.7 |
|
Interest payable on loans |
14.5 |
20.7 |
13.8 |
|
Other expenses |
1.3 |
1.4 |
0.2 |
|
Total expenses |
12.9 |
21.5 |
11.5 |
|
Profit before tax |
56.0 |
74.9 |
53.1 |
|
Provisions |
137.8 |
140.8 |
129.1 |
|
Other taxes |
1.0 |
0.9 |
0.4 |
|
Total taxation |
19.7 |
20.2 |
26.9 |
|
Net profit |
35.3 |
53.8 |
25.8 |
Annual Balance Sheet
Financials in: USD
(mil)
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.696986 |
0.719399 |
0.683971 |
|
Consolidated |
Yes |
Yes |
Yes |
|
|
|
|
|
|
Statutory reserves |
21.2 |
17.7 |
15.5 |
|
Other reserves |
-7.0 |
-10.9 |
-17.5 |
|
Total reserves |
14.2 |
6.8 |
-1.9 |
|
Profits for the year |
61.8 |
45.2 |
6.7 |
|
Total
stockholders equity |
259.6 |
229.1 |
203.0 |
|
Minority interests |
-1.9 |
-1.4 |
-1.3 |
|
Deferred taxation |
20.1 |
9.2 |
4.8 |
|
Other provisions |
99.8 |
91.1 |
90.0 |
|
Provision for pensions |
11.3 |
10.2 |
10.4 |
|
Provisions and allowances |
142.1 |
133.8 |
137.9 |
|
Other debentures |
96.8 |
122.5 |
123.7 |
|
Taxes and social security |
68.7 |
71.3 |
37.5 |
|
Total long-term
liabilities |
165.5 |
193.7 |
161.2 |
|
Trade creditors |
38.9 |
49.8 |
56.4 |
|
Advances received |
7.2 |
9.5 |
11.6 |
|
Other loans |
92.3 |
73.4 |
92.1 |
|
Taxation and social security |
107.7 |
97.1 |
114.0 |
|
Due to group companies |
4.8 |
3.2 |
2.0 |
|
Owing to participants |
0.6 |
0.5 |
0.6 |
|
Total current
liabilities |
251.5 |
233.6 |
276.7 |
|
Regularisation account |
10.1 |
6.9 |
6.7 |
|
Total
liabilities (including net worth) |
828.8 |
797.2 |
785.5 |
|
Patents |
32.1 |
25.1 |
64.6 |
|
Goodwill |
8.9 |
10.5 |
15.3 |
|
Intangibles |
41.0 |
35.7 |
80.5 |
|
Land and buildings |
126.9 |
112.1 |
118.2 |
|
Machinery and tools |
9.7 |
8.6 |
8.9 |
|
Fixtures and equipment |
126.9 |
112.1 |
118.2 |
|
Fixed assets under construction |
4.6 |
7.2 |
0.5 |
|
Total tangible
fixed assets |
213.9 |
185.5 |
174.6 |
|
Long-term investments |
1.2 |
1.2 |
0.3 |
|
Shares held in associated companies |
2.7 |
2.8 |
2.3 |
|
Participating interest |
4.6 |
6.1 |
8.1 |
|
Deposits |
0.2 |
0.4 |
0.3 |
|
Total financial
assets |
10.2 |
10.7 |
16.3 |
|
Loans to associated companies |
1.5 |
0.2 |
0.5 |
|
Total
non-current assets |
265.1 |
231.9 |
271.4 |
|
Net stocks and work in progress |
251.4 |
253.3 |
222.2 |
|
Trade debtors |
187.4 |
212.8 |
214.3 |
|
Other receivables |
37.9 |
32.1 |
17.7 |
|
Total
receivables |
228.3 |
246.0 |
233.2 |
|
Owing from associated companies |
2.7 |
0.8 |
1.2 |
|
Owing from participants |
0.3 |
0.3 |
0.0 |
|
Cash and liquid assets |
64.0 |
42.2 |
37.6 |
|
Marketable securities |
0.2 |
0.3 |
0.1 |
|
Short-term investments |
0.2 |
0.3 |
0.1 |
|
Shares in associated companies |
0.1 |
0.0 |
4.7 |
|
Recoverable taxation |
14.0 |
16.9 |
15.1 |
|
Total current
assets |
543.9 |
541.9 |
493.0 |
|
Prepaid expenses and deferred costs |
5.8 |
6.5 |
6.1 |
|
Total assets |
828.8 |
797.2 |
785.5 |
Annual Ratios
Financials in: USD
(mil)
|
|
31-Dec-2009 |
31-Dec-2008 |
31-Dec-2007 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.696986 |
0.719399 |
0.683971 |
|
Consolidated |
Yes |
Yes |
Yes |
|
|
|
|
|
|
Current ratio |
21.63 |
23.20 |
17.82 |
|
Acid test ratio |
11.63 |
12.35 |
9.79 |
|
Total liabilities to net worth |
0.16% |
0.19% |
0.22% |
|
Net worth to total assets |
0.03% |
0.03% |
0.03% |
|
Current liabilities to net worth |
0.10% |
0.10% |
0.14% |
|
Current liabilities to stock |
0.10% |
0.09% |
0.12% |
|
Fixed assets to net worth |
0.10% |
0.10% |
0.13% |
|
Collection period |
551.00 |
628.00 |
683.00 |
|
Stock turnover rate |
2.02 |
2.05 |
1.93 |
|
Profit margin |
0.00% |
0.00% |
0.00% |
|
Return on assets |
0.01% |
0.01% |
0.01% |
|
Shareholders' return |
0.01% |
0.02% |
0.01% |
|
Sales per employee |
19.44 |
21.58 |
20.69 |
|
Profit per employee |
0.57 |
0.89 |
0.50 |
|
Net worth |
259.6 |
229.1 |
203.0 |
|
Number of employees |
4,457 |
4,114 |
3,798 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.07 |
|
UK Pound |
1 |
Rs.77.42 |
|
Euro |
1 |
Rs.67.72 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.